linkedin post 2013-02-26 12:30:16

Uncategorized
RECENT CARTOON: TWO YOUNG PEOPLE STARING AT AN OLDER PERSON READING A BOOK. "What is she doing?"True within the next decade? I just sold 2,500 books that I loved in part of a big move. I simply did not have space. Do I miss them? Yes. Can I live without them? Yes. Can I replace most of them electronically? In most cases, yes. Do I like traveling with 50 books on a Flashdrive? Yes. I think that the writing is on the wall. http://lnkd.in/TjVEfz View in LinkedIn
Read More

linkedin post 2013-02-28 12:28:42

Uncategorized
A EUROPEAN SCIENCE AND TECHNOLOGY ADVISORY COUNSEL has been created to advise on how to harness this economic driver. Firstly, it is a formal recognition of its economic importance. Secondly, it will influence capital expenditure. Assuming the advice forthcoming is halfway valuable, this is cause for optimism, and a sign that growing our way out of the Crisis is at least as important as austerity approaches in the eyes of Brussels. Watch this space. http://lnkd.in/2_afT9 View in LinkedIn
Read More

linkedin post 2013-03-03 02:45:24

Uncategorized
HOW MUCH STOCK TO GIVE IN EARLY TECH COMPANIES? The issue is most key for non-founders, since the founding team typically split the pie. The key is to give enough, but not too much. A hired-gun CEO can earn 5% post Series A; a CFO 1%; a CMO or CSO 4-5%; a COO 2-3%. Board members 1-2%, and SAB 1-2%, typically with double for the Chairman. It is important to give annual MBO based awards to keep them current, and always vesting straight line over 3-4 years. Try and leave enough in the SOP for future hires and distribution. View in LinkedIn
Read More

linkedin post 2013-02-28 12:06:48

Uncategorized
THIS BEAUTIFUL PICTOGRAM OF THE COST TO DEVELOP DRUGS BY BIG PHARMA is at the heart of the urban myth that discovering a new drug costs billions. While it is true for Big Pharma, it only costs that much because they are so inefficient. Small Biopharma companies can do it for 30 - 100 M USD. Do not let the incredible inefficiency of Big Pharma wrongly steal the headlines. It can, and is being done cheaply in small companies all over the world. http://lnkd.in/SNAjxE View in LinkedIn
Read More

linkedin post 2013-03-03 02:36:59

Uncategorized
IN EARLY STAGE TECH COMPANIES, HOW MUCH STOCK SHOULD YOU DISTRIBUTE? The true founders will likely take equal shares of the pie, and then dilute themselves to give stock to early key hires, as much as 5% each; quite early on it is important to creat an Option Pool for future hires, of about 20% pre-Series A, so that parameters are set on the extent of founder dilution. If the key members are not incentivized sufficiently, they may be lost. Too much, and equity has been wasted. View in LinkedIn
Read More

linkedin post 2013-02-28 11:54:32

Uncategorized
THE US ARMY HAD A BIO-SILK INITIATIVE TO REPLACE KEVLAR. The US Army research facility in Massachusetts has long been interested in spider silk as the toughest material in the universe (Young's Modulus), and invested in efforts to clone the gene. As a very large gene, and more complex than originally thought, this goal has been illusive. View in LinkedIn
Read More

linkedin post 2013-03-03 02:12:52

Uncategorized
SOMEBODY MUST HAVE MEASURED THE RATE OF CHANGE in our lives in terms of society, technology, medicine, and attitudes. It seems intuitive that the rate of change is accelerating. When you consider periods in history like the Dark Ages, where many believe that for 500 years nothing changed significantly, our epoch is a sharp contrast. And remember, we still are evolving biologically at a very slow rate: we have vestigial organs and teeth, our metabolism is geared for a hunter-gatherer lifestyle. Is this divergence in rate of change important? http://lnkd.in/vg8GvE View in LinkedIn
Read More

linkedin post 2013-02-28 02:08:19

Uncategorized
A GOVERNMENT BIOPLASTICS INITIATIVE IN THAILAND is a direct stimulus for creative entrepreneurs: take local cassava plant and convert it into biodegradable plastics. The challenge of this task is firstly, to do it in a scalable and cost-effective way so the consumer looks at parity pricing. Secondly, to ensure that the biodegradation is clean and has no biotoxicity. A worthy initiative indeed. http://lnkd.in/EUf-aH View in LinkedIn
Read More

linkedin post 2013-03-02 16:05:41

Uncategorized
GREEN CHEMISTRY is now (finally) becoming hot. Avoiding toxic solvents in process manufacturing and on final products has been forced upon some of the giant chemical companies by dint of the fact their suppliers were early adopters of green technology. In many cases, finding safe or safer alternative solvents has not been easy. http://lnkd.in/pvJkt9 View in LinkedIn
Read More